Trial intelligence / Profile preview

Reducing antibiotic use for uncomplicated urinary tract infection with Uva ursi

DRKS00011042Phase 3Completed

Sponsor
Universitätsmedizin Göttingen
Start
Sep 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of atorvastatin in urinary tract infection (UTI) (2 arms), sponsored by Universitätsmedizin Göttingen. Started Sep 2017; status: completed.

02

Drugs

atorvastatin
03

Conditions

urinary tract infection (UTI)

Beyond the preview

Go deeper on DRKS00011042.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on DRKS00011042.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call